%0 Journal Article
%T CDK4/6抑制剂在消化道肿瘤中的研究进展
Research Progress of CDK4/6 Inhibitors in Digestive Tract Tumors
%A 伊丽达娜·斯提瓦尔地
%A 毛睿
%J Advances in Clinical Medicine
%P 2893-2897
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.133409
%X CDK4/6作为调节细胞周期的关键蛋白激酶,在衰老、DNA修复等行为中也扮演着重要的角色,对于CDK4/6以及其抑制剂的应用的相关研究也正在进行中,近年来成为在各种癌症类型中进行热点探究的潜在靶点。本文就CDK4/6抑制剂在消化道肿瘤治疗的研究进展进行讨论。
As a key protein kinase that regulates cell cycle, CDK4/6 also plays an important role in aging, DNA repair and other behaviors. Relevant studies on the application of CDK4/6 and its inhibitors are al-so in progress. In recent years, CDK4/6 has become a potential target for hot research in various cancer types. This article discusses the progress of CDK4/6 inhibitors in the treatment of digestive tract tumors.
%K CDK4/6抑制剂,靶向治疗,消化道肿瘤
CDK4/6 Inhibitors
%K Targeted Therapy
%K Digestive Tract Tumors
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=61999